The pharmaceutical companies should provide moneys for drug testing, but have no influence on what studies are done or how they are performed. Only if we have the research at arm’s length from those in position to benefit from the study results can we have ethical evaluation of new drugs. Is this position anti-capitalistic? I argue that the public welfare requires that we have good data on drugs, diagnostic tests, etc.
Related Post:
Widget by [ Iptek-4u ]